Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.

about

Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway.

P2860

Q50218607-3BF63F28-D0DC-472E-AE15-93587BFC5086

P2860

Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.

Item

http://www.wikidata.org/entity/Q38785742

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Silibinin inhibits triple nega ...... suppressing TGF-β2 expression.

@en

type

Item

label

Silibinin inhibits triple nega ...... suppressing TGF-β2 expression.

@en

prefLabel

Silibinin inhibits triple nega ...... suppressing TGF-β2 expression.

@en

P1476

Silibinin inhibits triple nega ...... suppressing TGF-β2 expression.

@en

P2093

Daeun You

http://www.w3.org/2001/XMLSchema#string

Hee Jung Kim

http://www.w3.org/2001/XMLSchema#string

Jeong Eon Lee

http://www.w3.org/2001/XMLSchema#string

Jeonghun Han

http://www.w3.org/2001/XMLSchema#string

Jeongmin Lee

http://www.w3.org/2001/XMLSchema#string

Myeongjin Jeon

http://www.w3.org/2001/XMLSchema#string

Sangmin Kim

http://www.w3.org/2001/XMLSchema#string

Sarang Bae

http://www.w3.org/2001/XMLSchema#string

Seok Jin Nam

http://www.w3.org/2001/XMLSchema#string

P2860

Epithelial-mesenchymal transitions in development and disease

EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line

Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility

TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4

Specificity and versatility in tgf-beta signaling through Smads

TGF-beta-induced epithelial to mesenchymal transition

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.

Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases.

Fibronectin at a glance.

Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis.

P2888

s13277-016-5000-7

P304

11397-11407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-016-5000-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1019789498

http://www.w3.org/2001/XMLSchema#string

P698

26984157

http://www.w3.org/2001/XMLSchema#string

Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.

about

P2860

P2860

Silibinin inhibits triple negative breast cancer cell motility by suppressing TGF-β2 expression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698